PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-19.90%
Cash & equivalents declining -19.90% while AXSM's grows 0.70%. Howard Marks would question why our liquidity is shrinking while competitor builds cash.
No Data
No Data available this quarter, please select a different quarter.
-19.90%
Below half of AXSM's 0.70%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-18.69%
Below half of AXSM's 8.49%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
6.10%
Below half AXSM's -3.53%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both AXSM and the company show zero Long-Term Investments Growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.84%
≥ 1.5x AXSM's 1.11%. David Dodd sees significantly higher long-term asset buildup. Confirm synergy with strategy.
No Data
No Data available this quarter, please select a different quarter.
-18.44%
Below half of AXSM's 7.23%. Michael Burry sees a potential red flag for stagnation or capital shortage.
65.60%
Above 1.5x AXSM's 6.97%. Michael Burry questions if payables are being stretched to avoid short-term borrowing.
-100.00%
Less than half of AXSM's 15392.73%. David Dodd sees much smaller short-term leverage burden vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both AXSM and the company show zero Deferred Revenue (Current) Growth.
-13.55%
Less than half of AXSM's 14.15%. David Dodd sees fewer expansions in other current obligations.
-8.01%
Less than half of AXSM's 40.25%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.01%
Less than half of AXSM's 4.28%. David Dodd sees far fewer liability expansions relative to competitor.
7.31%
Higher Common Stock (Book Value) Growth compared to AXSM's zero value, indicating worse performance.
-7.62%
≥ 1.5x AXSM's -4.06%. David Dodd sees higher yoy retained profits than competitor.
-130.04%
Higher AOCI Growth compared to AXSM's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-45.22%
Below half AXSM's 37.35%. Michael Burry sees potential underperformance in building shareholder capital.
-18.44%
Below half AXSM's 7.23%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
-100.00%
Both AXSM and the company show zero Total Investments Growth.
-100.00%
Less than half of AXSM's 2.81%. David Dodd sees less overall debt expansion vs. competitor.
19.60%
Above 1.5x AXSM's 4.12%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.